Neil E. Fleshner - 31 Oct 2023 Form 4 Insider Report for POINT Biopharma Global Inc.

Role
Chief Medical Officer, Director
Signature
/s/ William L. Demers, by Power of Attorney for Neil E. Fleshner
Issuer symbol
N/A
Transactions as of
31 Oct 2023
Net transactions value
$0
Form type
4
Filing time
02 Nov 2023, 18:30:24 UTC
Previous filing
30 Mar 2023
Next filing
27 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PNT Common Stock Gift $0 -250,000 -8.3% $0.000000 2,773,045 31 Oct 2023 Direct F1
holding PNT Common Stock 233,171 31 Oct 2023 1510789 Ontario Inc. F2
holding PNT Common Stock 358 31 Oct 2023 Trust Controlled by Wife F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the gift of common stock to a charitable donor-advised fund.
F2 A corporation controlled by the Reporting Person.
F3 A trust, whose trustee is the Reporting Person's spouse.